IP Library Granted Patent US 11,175,295
Granted Patent B2
US 11,175,295 · App. 16/514,380 · Granted Nov 16, 2021

Antibodies and methods for the detection of cell death

Inventors: Jeffrey Allan Miller (Lincoln University, PA); Eddie Phillip Jeffries (Sterling, VA)
Assignee: Defined Diagnostics, LLC
G01N33/6893C07K16/18G01N33/54333C07K2317/33C07K2317/34C07K2317/56C07K2317/72G01N2333/4742G01N2510/00G01N2800/085G01N2800/7033
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,175,295
App. No.
16/514,380
Granted
Nov 16, 2021
Kind
B2
Abstract

Disclosed herein are antibodies having binding specificity to the amino acid sequences Ala Ser Ser Gly Leu Thr Val Glu Val Asp (SEQ ID NO:1) and Thr Val Glu Val Asp (SEQ ID NO:14), and methods of detecting cell death in a sample, comprising contacting the sample with a first antibody specific for a C-terminal amino acid sequence Ala Ser Ser Gly Leu Thr Val Glu Val Asp (SEQ ID NO:1) or Thr Val Glu Val Asp (SEQ ID NO:14) of a CK18 protein fragment having a C-terminal amino acid sequence of Val Glu Val Asp (SEQ ID NO:2) and a second antibody that specifically binds an epitope that is present in both full-length CK18 and the CK18 protein fragment, and that does not overlap with SEQ ID NO:1 or SEQ ID NO:14, under conditions such that the CK18 protein fragment present in the sample specifically binds to the first antibody and the second antibody, wherein one of the antibodies is bound to a solid support and the other antibody is bound to a detection moiety capable of producing a signal; optionally removing any unbound or excess material; and detecting the signal from the detection moiety, wherein the signal is positively correlated with the presence of the CK18 protein fragment in the sample.

Claims (8)

1. An antibody wherein the antibody has binding specificity to the amino acid sequence Ala Ser Ser Gly Leu Thr Val Glu Val Asp (SEQ ID NO:1), wherein the antibody comprises a variable region of the heavy chain amino acid sequence of SEQ ID NO:5, and a variable region of the light chain amino acid sequence of SEQ ID NO:7.

2. The antibody of claim 1 , wherein the antibody is coupled to a solid support or a detection moiety.

3. The antibody of claim 2 , wherein the antibody is directly bound to the solid support or the detection moiety.

4. The antibody of claim 2 , wherein the antibody is indirectly bound to the solid support or the detection moiety.

5. The antibody of claim 2 , wherein the detection moiety is selected from the group consisting of electrochemiluminescence labels or compounds, chemiluminescent compounds, enzyme labels, fluorophores, chromogenic compounds, radiolabels, catalysts, colorimetric, labeled antibodies, a latex particle, a magnetic particle, a paramagnetic particle, a radioactive element, fluorescent dyes, phosphorescent dyes, dye crystals, gold particles, silver colloidal particles, selenium colloidal particles, metal chelates, coenzymes, electro active groups, oligonucleotides and stable radicals.

6. The antibody of claim 5 , wherein the metal chelate is a ruthenium, an osmium, or a europium metal chelate.

7. The antibody of claim 2 , wherein the solid support is selected from the group consisting of a bead, a plate, a glass surface, a plastic surface, a metal surface, a polystyrene surface, a nitrocellulose surface, a microparticle and a nanoparticle surface.

8. The antibody of claim 7 , wherein the solid support is a bead.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2023
From: DEFINED DIAGNOSTICS, LLC (FORMERLY KNOWN AS WELLSTAT DIAGNOSTICS, LLC)
To: PDL BIOPHARMA, INC.
Reel/Frame 065823/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2023
From: MILLER, JEFFREY ALLAN; JEFFRIES, EDDIE PHILLIP
To: WELLSTAT DIAGNOSTICS, LLC.
Reel/Frame 065817/0656 →
CHANGE OF NAME Recorded Dec 8, 2023
From: WELLSTAT DIAGNOSTICS, LLC
To: DEFINED DIAGNOSTICS, LLC
Reel/Frame 066140/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2023
From: DEFINED DIAGNOSTICS, LLC (F/K/A WELLSTAT DIAGNOSTICS, LLC)
To: PHARMA CINQ, LLC
Reel/Frame 065769/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2021
From: PDL BIOPHARMA, INC.
To: DEFINED DIAGNOSTICS, LLC (F/K/A WELLSTAT DIAGNOSTICS, LLC)
Reel/Frame 055313/0842 →
Continuity (4)
Division 15127644
Provisional Application 61987668 · May 2, 2014
Provisional Application 61968016 · Mar 20, 2014
Related Publication 20200041526A1 · Feb 6, 2020